Cambridge Investment Research Advisors
AWH

Cambridge Investment Research Advisors’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Cambridge Investment Research Advisors’s Portfolio AWH Stock Details AWH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-834
Closed -$70K – 3230
2021
Q2 		$70K Buy
834
+11
+1% +$945 ﹤0.01% 3003
2021
Q1 		$83K Hold
823
– – ﹤0.01% 2782
2020
Q4 		$83K Hold
823
– – ﹤0.01% 2623
2020
Q3 		$38K Buy
+823
New +$42.2K ﹤0.01% 2461

Other funds holding AWH

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cambridge Investment Research Advisors's AWH Position: Q3 2021 in Review

Cambridge Investment Research Advisors sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q3 2021, closing a stake of 834 shares — an estimated $70K sold.

Cambridge Investment Research Advisors first reported a position in AWH in Q3 2020 and held it in 4 quarters. The position peaked at $83K in Q1 2021. 92 funds tracked by Wall St. Rank hold AWH as of Q3 2021.

  • Cambridge Investment Research Advisors reported no remaining Aspira Women's Health Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 834 Aspira Women's Health Inc. Common Stock shares in Q3 2021, an estimated $70K.
  • Cambridge Investment Research Advisors first reported a position in Aspira Women's Health Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Cambridge Investment Research Advisors's Aspira Women's Health Inc. Common Stock position peaked at $83K in Q1 2021.
  • 92 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q3 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.